Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients

التفاصيل البيبلوغرافية
العنوان: Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients
المؤلفون: George Boon-Bee Goh, Ruth Sargent, Srinivasan Dasarathy, Jaividhya Dasarathy, Aynur Unalp-Arida, Achuthan Sourianarayanane, Rish K. Pai, Arthur J. McCullough, Mangesh R. Pagadala, Carol Hawkins, Amer Khiyami, Lisa Yerian
المصدر: BBA Clinical
بيانات النشر: Elsevier BV, 2015.
سنة النشر: 2015
مصطلحات موضوعية: Very low-density lipoprotein, BMI, body mass index, LDL, low density lipoprotein cholesterol, INR, international normalised ratio, AST, aspartate aminotransferase, Disease, Gastroenterology, Fibrosis score, NFS, NAFLD fibrosis score, DM, type 2 diabetes mellitus, apoB-100, apolipoprotein B-100, NAS, NAFLD activity score, TGs, triglycerides, Fatty liver, Regular Article, Non-diabetic, ACE-I, angiotensin-converting enzyme-inhibitor, 3. Good health, ARB, angiotensin receptor blocker, Molecular Medicine, Non diabetic, NAFLD, non-alcoholic fatty liver disease, medicine.medical_specialty, NASH, non-alcoholic steatohepatitis, NASH CRN, Non-alcoholic Steatohepatitis Clinical Research Network, ORs, odd ratios, digestive system, VLDL, very-low-density lipoproteins, Pathology and Forensic Medicine, ER, endoplasmic reticulum, Diabetic, ALT, alanine aminotransferase, NAFLD, Physiology (medical), Diabetes mellitus, Internal medicine, medicine, FFAs, free-fatty acids, In patient, Chol, total cholesterol, ALP, alkaline phosphatase, business.industry, SDs, standard deviations, nutritional and metabolic diseases, Non alcoholic, NAFLD fibrosis score, medicine.disease, CIs, confidence intervals, digestive system diseases, HDL, high density lipoprotein cholesterol, Endocrinology, HOMA-IR, Homeostatic model assessment—insulin resistance, business
الوصف: Background While non-alcoholic fatty liver disease (NAFLD) has been well characterised in patients with diabetes mellitus (DM), less is known about NAFLD in non-DM patients. We investigated the clinical characteristics of NAFLD patients with and without DM and accuracy of the NAFLD fibrosis score (NFS) in these two NAFLD groups. Methods Clinical, biochemical and histological variables were evaluated in this prospective cross-sectional study of 503 patients with biopsy proven NAFLD. Comparisons between patients with and without DM were analysed. NFS was correlated with liver histology to assess its robustness in patients with and without DM. Results There were 503 biopsy proven NAFLD patients with 48% of the cohort being diabetic. Relative to patients without DM, patients with DM were older (52 vs. 46 years, p
Highlights • Patients with diabetes have more severe NAFLD based on histology. • Severe NAFLD can occur in a considerable proportion of non-diabetic NAFLD patients. • The NAFLD fibrosis score may be less accurate in non-diabetics.
تدمد: 2214-6474
DOI: 10.1016/j.bbacli.2014.09.001
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7eb9348140df9a8c541a554f5a132dTest
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....2a7eb9348140df9a8c541a554f5a132d
قاعدة البيانات: OpenAIRE
الوصف
تدمد:22146474
DOI:10.1016/j.bbacli.2014.09.001